Signatera-Guided De-escalation of Adjuvant Therapy in Resectable Stage II-IVa Gastric/Gastric-Esophageal Cancer
Clinical trial NCT07565857 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07565857
- Sponsor
- Natera, Inc.
- Status
- NOT_YET_RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2026-09-01
- Primary completion
- 2028-09-01
- Enrollment
- 1000
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.